Status:

COMPLETED

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Lead Sponsor:

Azienda Ospedaliera San Giovanni Battista

Conditions:

Hepatitis B Virus

Allograft

Eligibility:

All Genders

18-75 years

Brief Summary

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • All patients undergoing an allograft for hematological malignancies

Exclusion

    Key Trial Info

    Start Date :

    Trial Type :

    OBSERVATIONAL

    End Date :

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00876148

    Last Update

    April 6 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Azienda ospedaliera S Giovanni Battista

    Torino, Italy

    Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting | DecenTrialz